Literature DB >> 30703750

Polypeptide GalNAc-Ts: from redundancy to specificity.

Matilde de Las Rivas1, Erandi Lira-Navarrete2, Thomas A Gerken3, Ramon Hurtado-Guerrero4.   

Abstract

Mucin-type O-glycosylation is a post-translational modification (PTM) that is predicted to occur in more than the 80% of the proteins that pass through the Golgi apparatus. This PTM is initiated by a family of polypeptide GalNAc-transferases (GalNAc-Ts) that modify Ser and Thr residues of proteins through the addition of a GalNAc moiety. These enzymes are type II membrane proteins that consist of a Golgi luminal catalytic domain connected by a flexible linker to a ricin type lectin domain. Together, both domains account for the different glycosylation preferences observed among isoenzymes. Although it is well accepted that most of the family members share some degree of redundancy toward their protein and glycoprotein substrates, it has been recently found that several GalNAc-Ts also possess activity toward specific targets. Despite the high similarity between isoenzymes, structural differences have recently been reported that are key to understanding the molecular basis of both their redundancy and specificity. The present review focuses on the molecular aspects of the protein substrate recognition and the different glycosylation preferences of these enzymes, which in turn will serve as a roadmap to the rational design of specific modulators of mucin-type O-glycosylation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30703750      PMCID: PMC6656595          DOI: 10.1016/j.sbi.2018.12.007

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  46 in total

Review 1.  Mucins in cancer: protection and control of the cell surface.

Authors:  Michael A Hollingsworth; Benjamin J Swanson
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.

Authors:  Thomas A Gerken; Oliver Jamison; Cynthia L Perrine; Jeremy C Collette; Helen Moinova; Lakshmeswari Ravi; Sanford D Markowitz; Wei Shen; Himatkumar Patel; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

3.  Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions.

Authors:  Nis Borbye Pedersen; Shengjun Wang; Yoshiki Narimatsu; Zhang Yang; Adnan Halim; Katrine Ter-Borch Gram Schjoldager; Thomas Daugbjerg Madsen; Nabil G Seidah; Eric Paul Bennett; Steven B Levery; Henrik Clausen
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

Review 4.  Location, location, location: new insights into O-GalNAc protein glycosylation.

Authors:  David J Gill; Henrik Clausen; Frederic Bard
Journal:  Trends Cell Biol       Date:  2010-12-08       Impact factor: 20.808

Review 5.  Cancer glycan epitopes: biosynthesis, structure and function.

Authors:  Oliver M T Pearce
Journal:  Glycobiology       Date:  2018-09-01       Impact factor: 4.313

Review 6.  Mucins in cancer: function, prognosis and therapy.

Authors:  Donald W Kufe
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 7.  Tn and STn are members of a family of carbohydrate tumor antigens that possess carbohydrate-carbohydrate interactions.

Authors:  Marit Sletmoen; Thomas A Gerken; Bjørn T Stokke; Joy Burchell; C Fred Brewer
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

8.  Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.

Authors:  Johannes W Pedersen; Eric P Bennett; Katrine T-B G Schjoldager; Morten Meldal; Andreas P Holmér; Ola Blixt; Emiliano Cló; Steven B Levery; Henrik Clausen; Hans H Wandall
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

9.  Stepwise catalytic mechanism via short-lived intermediate inferred from combined QM/MM MERP and PES calculations on retaining glycosyltransferase ppGalNAcT2.

Authors:  Tomáš Trnka; Stanislav Kozmon; Igor Tvaroška; Jaroslav Koča
Journal:  PLoS Comput Biol       Date:  2015-04-07       Impact factor: 4.475

10.  The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.

Authors:  Gaetan G Herbomel; Raul E Rojas; Duy T Tran; Monica Ajinkya; Lauren Beck; Lawrence A Tabak
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

View more
  23 in total

1.  Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.

Authors:  Matilde de Las Rivas; Earnest James Paul Daniel; Yoshiki Narimatsu; Ismael Compañón; Kentaro Kato; Pablo Hermosilla; Aurélien Thureau; Laura Ceballos-Laita; Helena Coelho; Pau Bernadó; Filipa Marcelo; Lars Hansen; Ryota Maeda; Anabel Lostao; Francisco Corzana; Henrik Clausen; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Nat Chem Biol       Date:  2020-01-13       Impact factor: 15.040

2.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line.

Authors:  Mathias I Nielsen; Noortje de Haan; Weston Kightlinger; Zilu Ye; Sally Dabelsteen; Minyan Li; Michael C Jewett; Ieva Bagdonaite; Sergey Y Vakhrushev; Hans H Wandall
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

4.  Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.

Authors:  Earnest James Paul Daniel; Matilde Las Rivas; Erandi Lira-Navarrete; Ana García-García; Ramon Hurtado-Guerrero; Henrik Clausen; Thomas A Gerken
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

Review 5.  Mucins as anti-cancer targets: perspectives of the glycobiologist.

Authors:  Inka Brockhausen; Jacob Melamed
Journal:  Glycoconj J       Date:  2021-03-11       Impact factor: 2.916

Review 6.  In vivo models of mucin biosynthesis and function.

Authors:  Zulfeqhar A Syed; Liping Zhang; Kelly G Ten Hagen
Journal:  Adv Drug Deliv Rev       Date:  2022-03-09       Impact factor: 17.873

7.  COSMC mutations reduce T-synthase activity in advanced Alzheimer's disease.

Authors:  Seema Gollamudi; Rukmani Lekhraj; Shirin Lalezari; Parviz Lalezari
Journal:  Alzheimers Dement (N Y)       Date:  2020-06-26

8.  A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.

Authors:  Rohitesh Gupta; Frank Leon; Sanchita Rauth; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

9.  Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs.

Authors:  Junwon Choi; Lauren J S Wagner; Suzanne B P E Timmermans; Stacy A Malaker; Benjamin Schumann; Melissa A Gray; Marjoke F Debets; Megumi Takashima; Jase Gehring; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2019-08-16       Impact factor: 15.419

10.  Structural basis for peptide substrate specificities of glycosyltransferase GalNAc-T2.

Authors:  Sai Pooja Mahajan; Yashes Srinivasan; Jason W Labonte; Matthew P DeLisa; Jeffrey J Gray
Journal:  ACS Catal       Date:  2021-02-19       Impact factor: 13.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.